Hostname: page-component-586b7cd67f-dlnhk Total loading time: 0 Render date: 2024-11-26T22:25:38.240Z Has data issue: false hasContentIssue false
  • English
  • Français

Maintenance pharmacotherapy of unipolar depression

Published online by Cambridge University Press:  02 January 2018

Som Forshall  and
David J. Nutt
Som Forshall*
Affiliation:
School of Medical Sciences, University of Bristol BS8 1TD
David J. Nutt
Affiliation:
School of Medical Sciences, University of Bristol BS8 1TD
*
∗Correspondence
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Aims and methods

The purpose of this paper is to review current evidence and opinion with regard to the long-term treatment of unipolar depression. The method employed was a Psychlit search using the search items long-term, maintenance, treatment and depression.

Results

The search yielded 91 articles.

Clinical implications

Unipolar depression is frequently recurrent and sometimes a chronic illness. The paper identifies those at greatest risk of recurrence. It goes on to examine strategies to prevent relapse and for prophylactic treatment. It concludes that continuation treatment should be sustained at full dose for 4–6 months after full remission of symptoms. Where depression is highly recurrent the acute phase dose should be maintained in the long-term.

Type
Drug information quarterly
Information
Psychiatric Bulletin , Volume 23 , Issue 6 , June 1999 , pp. 370 - 373
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © 1999 The Royal College of Psychiatrists

References

American Psychiatric Association (1993) Practice guidelines for major depressive disorder in adults. American Journal of Psychiatry, 150 (suppl.). 1 26.Google Scholar
Angst, J. (1992) How recurrent and predictable is depressive illness? In Long-term Treatment of Depression (eds Montgomery, S. & Rouillon, F.). New York: John Wiley.Google Scholar
Frank, E., Kupfer, D., Pere, J., et al (1990) Three-year outcomes for maintenance therapies in recurrent depression. Archives of General Psychiatry, 47, 1093 1099.CrossRefGoogle ScholarPubMed
Frank, E., Kupfer, D., Pere, J., et al (1993) Comparison of full-dose versus half-dose pharmacotherapy in the maintenance treatment of recurrent depression. Journal of Affective Disorder, 27, 139 145.CrossRefGoogle ScholarPubMed
GEORGotis, A., McCue, R. E. & Cooper, T. B. (1989) A placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients. Archives of General Psychiatry, 46, 783 786.Google Scholar
Hamilton, M. (1967) Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology, 6, 278 296.CrossRefGoogle ScholarPubMed
Johnstone, W. C., Owens, D. G. C., Lambert, M. T., et al (1990) Combination tricyclic antidepressant and lithium maintenance medication in unipolar and bipolar depressed patients. Journal of Affective Disorder, 20, 225 233.Google Scholar
Keller, M. B. (1994) Depression: a long-term illness. British Journal of Psychiatry, 165 (suppl. 26), 9 15.CrossRefGoogle Scholar
Montgomery, S. A. (1994) Long-term treatment of depression. British Journal of Psychiatry, 165 (suppl. 26), 31 36.Google Scholar
Prien, R. F. & Kocsis, J. H. (1995) Long-term treatment of mood disorders. In Psychopharmacology: the Fourth Generation of Progress (eds Bloom, F. E. & Kupfer, D. J.). pp. 1067 1079. New York: Raven Press.Google Scholar
Sackeim, H., Prudic, J., Devanand, D. P., et al (1990) The impact of medication resistance and continuation pharmacotherapy on relapse following responses to electroconvulsive therapy in major depression. Journal of Clinical Psychopharmacology, 10, 96 104.CrossRefGoogle ScholarPubMed
Thase, M. E. (1992) Long-term treatments of recurrent depressive disorders. Journal of Clinical Psychiatry, 53 (suppl. 9), 32 44.Google ScholarPubMed
World Health Organization Mental Health Collaborating Centres (1989) Pharmacotherapy of depressive disorders: a consensus statement. Journal of Affective Disorders, 17, 197 198.CrossRefGoogle Scholar
Submit a response

eLetters

No eLetters have been published for this article.